Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.
Ellie Henry from Milton Keynes developed Ehlers-Danlos syndrome - a connective tissue disorder – as a teenager. "I hope that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback